2023 BCLT Privacy Law Forum: Life Sciences
Tuesday, November 14
9:00 A.M. – 3:30 P.M. (PT)
Virtual / B-CLE Webcast
Enroll Now | Agenda
CLE and CPE credit will be offered!
This fall, BCLT’s Life Sciences Law & Policy Center and Privacy Law at Berkeley are excited to launch the new BCLT Privacy Law Forum: Life Sciences conference! Building on the success of the Annual BCLT Privacy Law Forum (which regularly sees many thousands of registrants), the Privacy Law Forum: Life Sciences conference will explore key issues at the interface of life sciences technologies and privacy and cybersecurity legal regimes. In-house counsel, practitioners, regulators, and academics will join to share their perspectives, research, and analysis of what you need to know now to handle urgent privacy concerns, and what you will want to watch for the future. This is a must-view program for anyone who is encountering privacy issues in the context of the life sciences ecosystem.
The BCLT Privacy Law Forum: Life Sciences program provides registrants with the option to join the event live or stream the event later on B-CLE.
About B-CLE
-
Biotechnology & Inventorship – What You Need To Know
-
Part 1: Inventorship Determinations: Disputes and Best Practices
- September 19, 2023
- In part one, Inventorship Determinations: Disputes and Best Practices, join BCLT Life Sciences Director Allison Schmitt in conversation with Brent Sokol, an experienced biotech litigator, and Micheal Hebert, a leading life science patent prosecutor. We discuss the legal standard for inventorship, provide case examples, and share best practices for determining inventorship and handling disputes during prosecution.
-
Part 2: Trade Secrets and Inventorship: Disputes and Best Practices
- September 26, 2023
- In part two, Trade Secrets and Inventorship: Disputes and Best Practices, join BCLT Life Sciences Director Allison Schmitt in conversation with Brent Sokol, an experienced biotech litigator, and Greg Bombard, a widely-recognized trade secret trial lawyer provide an overview of trade secret law. We recommend best practices for trade secret protection, and explore inventorship issues as they arise in the context of trade secret disputes.
-
Part 3: Transactions and Inventorship: Best Practices for Diligence and Covenants
- October 3, 2023
- In part three, Transactions and Inventorship: Best Practices for Diligence and Covenants, join BCLT Life Sciences Director Allison Schmitt in conversation with Brent Sokol, an experienced biotech litigator, and Prashant Girinath, a top life sciences patent strategist. We examine the law of inventorship, recommend best practices for transaction readiness and diligence, and provide case examples in which an inventorship dispute impacted a commercial transaction.
-
- 2022 BCLT Advanced Life Sciences Institute
April 22, 2022
Agenda -
Carving out Induced Infringement: Update on Skinny Labels
April 6, 2022
12:00 – 1:00 PM PT
ResourcesSpeakers: Mila Owen(opens in a new tab), White & Case, and Allison Schmitt(opens in a new tab), BCLT
- Nov. 10, 2021: Berkeley Law AI Institute Panel on AI, Life Sciences and Healthcare (Moderator: Allison Schmitt; Panelists: Susan Tull (Latham & Watkins LLP), Andrea Wang (CEO, AHEAD Medicine), Vadim Nasarov (CEO, Immunomind))
- Nov. 10, 2021: BTLJ-CMTL-BCLT Symposium: Race & Technology Law: Innovating Health Equity.
o Panels on Promises of Technological Innovation & Its Equitable Distribution, and Equitable and Ethical Development of Novel Applied Technology & Potential for Misuse (co-moderated by Allison Schmitt)
o Fireside Chat with Dean Dayna Bowen Matthew (GW Law) on the Potential Application of Affordable Care Act § 1557 to Combat Structural Inequities in Healthcare (hosted by Allison Schmitt)
The Life Sciences Project explores issues central to understanding what drives innovation in the life sciences, including the factors affecting innovation in the pharmaceutical and healthcare spaces. Current topics include:
- Challenges with IP protection for life sciences inventions, including subject matter eligibility, written description and enablement, and application of trade secrets;
- Drug pricing and competition issues in the pharmaceutical industry;
- Comparative life science litigation and regulation issues related to pharmaceutical development worldwide;
- Emerging challenges with regulation and litigation on transformative life sciences technologies;
- IP protection and regulatory issues related to technologies that integrate life sciences and high technology, such as AI and digital health;
- Use of data in pharmaceutical and healthcare spaces, and the privacy issues arising from that use;
- Public health issues on a global level, including issues related to preparedness for future pandemics; and
- Promoting equity and justice in healthcare.
Allison Schmitt
Fellow and Director, BCLT Life Sciences Project
aaschmitt@berkeley.edu